ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AGLE Aeglea BioTherapeutics Inc

12.01
0.00 (0.00%)
Pre Market
Last Updated: 11:00:00
Delayed by 15 minutes

Aeglea BioTherapeutics Financial Summary

The current AGLE market cap is 48.63M. The company's latest EPS is USD -83.6725 and P/E is -0.44.

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 174k168k198k688k0
Operating Income -18.76M-19.16M-18.81M-159.25M-32.95M
Net Income -18.23M-18.82M-18.42M-217.08M-40.16M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0018.74M2.33M886k
Operating Income -80.33M-81.48M-65.65M-84.78M-258.75M
Net Income -78.25M-80.89M-65.8M-83.82M-338.79M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 91.57M71.14M52.45M243.53M207.27M
Total Liabilities 24.01M20.84M18.8M253.58M65.56M
Total Equity 67.56M50.31M33.65M-207.37M-245.4M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 83.18M161.62M109.93M71.14M341.86M
Total Liabilities 23.1M21.79M25.99M20.84M73.29M
Total Equity 60.08M139.83M83.94M50.31M184.02M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -62M-80.14M-17.63M-34.28M-68.87M
Investing 43.01M57.01M17.75M24.51M-73.12M
Financing 42.69M42.68M10k210M197.47M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -65.69M-75.78M-53.72M-80.14M-99.91M
Investing -1.74M-7.6M-22.62M57.01M-108.39M
Financing 65.72M154.51M1.39M42.68M361.08M
Market Cap 48.63M
Price to Earnings Ratio -0.44
Price to Sales Ratio 169.1
Price to Cash Ratio 0.79
Price to Book Ratio 0.56
Dividend Yield -

Share Statistics

Shares Outstanding 4.05M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change 54.12%
52 Week High 24.00
52 Week Low 2.66
Spread (Intraday) 2.8 (20%)

Company Info

Company Name Aeglea BioTherapeutics Inc
Address 1521 concord pike
wilmington, delaware 19803
Website https://www.spyre.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock